Methimazole Associated Neutropenia in a Preterm Neonate Treated for Hyperthyroidism
Maternal Graves’ disease is relatively uncommon with an estimated incidence of 0.4%–1% of all pregnancies, but only 1–5% of newborns delivered to mothers with Graves’ disease develop overt clinical signs and symptoms of hyperthyroidism. Here, we describe a case of a 1380-gram female neonate who was...
Saved in:
| Main Authors: | Dimitrios Angelis, Rita Ann Kubicky, Alan B. Zubrow |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/680191 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Feline hyperthyroidism associated with chronic renal disease and diabetes mellitus after treatment with methimazole – A case study
by: Pap, Andreea, et al.
Published: (2017-12-01) -
Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves’ Hyperthyroid Patients: A Randomized Prospective Controlled Study
by: Raweewan Lertwattanarak, et al.
Published: (2022-01-01) -
Unusual Synchronous Methimazole-Induced Agranulocytosis and Severe Hepatotoxicity in Patient with Hyperthyroidism: A Case Report and Review of the Literature
by: Jun Yang, et al.
Published: (2015-01-01) -
Efficacy of selenium supplementation for patients with Graves' hyperthyroidism during methimazole treatment: protocol for a systematic review and meta-analysis
by: Mingxing Li, et al.
Published: (2024-09-01) -
Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil
by: Jaeduk Yoshimura Noh, et al.
Published: (2024-07-01)